Among the others, two-thirds of the AQP4+ patients had reported symptoms associated with urinary tract and/or bowel dysfunction, while this was rarer (less than one-third) in MOG+ and double-seronegative patients. The gene discussed is MOG; the disease is bowel dysfunction.